The Nigerian Cancer Society (NCS) has unveiled plans to establish a National Cancer Intervention Fund aimed at improving cancer treatment, care, and awareness across Nigeria.
Speaking at a seminar and media parley on HPV vaccine uptake in Abuja on Saturday, NCS President, Prof. Abidemi Omonisi, stressed the urgent need for increased funding to tackle the nation’s growing cancer burden.
“The government is committed to addressing cancer in Nigeria, but we need more resources to effectively tackle the disease. This initiative aims to raise at least ₦10 billion to support treatment, research, and awareness programs,” Omonisi said.
Key Objectives of the Fund
The fund, scheduled for an official launch on World Cancer Day, will be an independent initiative supported by leading figures in the medical, philanthropic, and legal sectors. It will focus on:
Enhancing access to affordable cancer treatments.
Supporting research and innovation in cancer care.
Increasing public awareness about cancer prevention and early detection.
Omonisi noted that despite some progress in the fight against cancer, care remains underfunded, leaving many Nigerians without access to critical treatment. He emphasized the NCS’s commitment to mobilizing both public and private sector resources to bridge this gap.
“We are collaborating with international partners to strengthen local cancer care infrastructure so that Nigerians no longer need to seek treatment abroad,” he added.
HPV Vaccine Advocacy
At the seminar, Dr. Uzoma, a consultant to the NCS, highlighted the importance of addressing myths and misconceptions surrounding the HPV vaccine to improve its acceptance in Nigeria.
“HPV is a known precursor to cervical cancer, the second leading cause of cancer worldwide. Advocacy is critical to dispel myths and ensure no girl or daughter is left behind,” Uzoma said.
He urged stakeholders to support the Federal Ministry of Health’s efforts to prevent cervical cancer and ensure widespread vaccine adoption.
Call to Action
The NCS called on prominent Nigerians, organizations, and stakeholders to rally behind the initiative and contribute to the fund.
This initiative is expected to be a game-changer, improving the quality of life for cancer patients and advancing efforts to reduce cancer-related mortality in Nigeria.
